Abstract:Background: Cancer is a highly heterogeneous disease, driven by frequent genetic alterations which have significant effects on radiosensitivity. However, radiotherapy for a given cancer type is typically given with a standard dose determined from population-level trials. As a result, a proportion of patients are under- or over-dosed, reducing the clinical benefit of radiotherapy. Biological optimization would not only allow individual dose prescription but also a more efficient allocation of limited resources, such as proton and carbon ion therapy. Proton and ion radiotherapy offer an advantage over photons due to their elevated Relative Biological Effectiveness (RBE) resulting from their elevated Linear Energy Transfer (LET). Despite significant interest in optimizing LET by tailoring radiotherapy plans, RBE's genetic dependence remains unclear. Purpose: The aim of this study is to better define the RBE/LET relationship in a panel of cell lines with different defects in DSB repair pathways, but otherwise identical biological features and genetic background to isolate these effects. Methods: Normal human cells (RPE1), genetically modified to introduce defects in DNA double-strand break (DSB) repair genes, ATM, BRCA1, DCLRE1C, LIG4, PRKDC and TP53, were used to map the RBE-LET relationship. Cell survival was measured with clonogenic assays after exposure to photons, protons (LET 1 and 12 keV/µm) and alpha particles (129 keV/µm). Gene knockout sensitizer enhancement ratio (SER) values were calculated as the ratio of the mean inactivation dose (MID) of wild-type cells to repair-deficient cells, and RBE values were calculated as the ratio of the MID of X-ray and particle irradiated cells. 53BP1 foci were used to quantify radiation-induced DSBs and their repair following irradiation. Results: Deletion of NHEJ genes had the greatest impact on photon sensitivity (ATM-/- SER = 2.0 and Lig4-/- SER = 1.8), with genes associated with HR having smaller effects (BRCA1-/- SER = 1.2). Wild-type cells showed RBEs of 1.1, 1.3, 5.0 for low- and high-LET protons and alpha particles respectively. SERs for different genes were independent of LET, apart from NHEJ knockouts which proved to be markedly hypersensitive across all tested LETs. Due to this hypersensitivity, the impact of high LET was reduced in cell models lacking the NHEJ repair pathway. HR-defective cells had moderately increased sensitivity across all tested LETs, but, notably, the contribution of HR pathway to survival appeared independent of LET. Analysis of 53BP1 foci shows that NHEJ-defective cells had the least DSB repair capacity after low LET exposure, and no visible repair after high LET exposure. HR-defective cells also had slower repair kinetics, but the impact of HR defects is not as severe as NHEJ defects. Conclusions: DSB repair defects, particularly in NHEJ, conferred significant radiosensitivity across all LETs. This sensitization appeared independent of LET, suggesting that the contribution of different DNA repair pathways to survival does not depend on radiation quality.

Mechanism of the DNA Damage Repair Gene Work on Elevated Α/β Value after Hypofractionated Radiotherapy for Prostate Cancer

Elevated Α/β Ratio after Hypofractionated Radiotherapy Correlated with DNA Damage Repairment in an Experimental Model of Prostate Cancer.

Effect of Low Does Irradiation on Expression of DNA Repair Genes and Ced Cycle of A549 and 2BS Cells

Variability of Α/β Ratios for Prostate Cancer with the Fractionation Schedule: Caution Against Using the Linear-Quadratic Model for Hypofractionated Radiotherapy

DNA Damage Response in Prostate Cancer Cells by Proton Microbeam Irradiation

Most DNA repair defects do not modify the relationship between relative biological effectiveness and linear energy transfer in CRISPR-edited cells

Repair rates of DNA double-strand breaks under different doses of proton and γ-ray irradiation

The Linear-Quadratic (LQ) Model is Inappropriate for High Doses Per Fraction Owing to Α/β Ratio is Not a Constant: Evidence Deduced from Radiotherapy Outcomes of 16367 Prostate Cancer Patients.

Supplementary Figures from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Investigation of DNA Damage and Cell-Cycle Distribution in Human Peripheral Blood Lymphocytes under Exposure to High Doses of Proton Radiotherapy

Repair of Alpha-Particle-induced DNA Double Strand Breaks and Their Localization in Chromatin in Human Lymphocytes

Effects of Different Doses of X-ray Irradiation on Cell Apoptosis, Cell Cycle, DNA Damage Repair and Glycolysis in HeLa Cells

The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons

Dose-Dependent Shift in Relative Contribution of Homologous Recombination to DNA Repair after Low-LET Ionizing Radiation Exposure: Empirical Evidence and Numerical Simulation

Radiation dose effect on non-small cell lung cancer based on driver genotyping: An exploratory study

DNA Repair Capacity and Acute Radiotherapy Adverse Effects in Italian Breast Cancer Patients

Impact of kV-cone beam computed tomography dose on DNA repair mechanisms: A pilot study

Modeling of DNA Damage Repair and Cell Response in Relation to p53 System Exposed to Ionizing Radiation

Radiation responses of cancer and normal cells to split dose fractions with uniform and grid fields: increasing the therapeutic ratio

Generalized Multi-Hit Model Of Radiation-Induced Cell Survival With A Closed-Form Solution: An Alternative Method For Determining Isoeffect Doses In Practical Radiotherapy

Exploring DNA repair deficient CHO cell response to low dose rate radiation